Topic and Speaker
7:30am – 7:55am
Registration and Continental Breakfast
7:55am – 8:00am
8:00am – 8:30am
Cell-Based Therapies for AMD
Mark Humayun, MD, PhD
8:30am – 9:00am
Novel Therapeutics for Inherited Retinal Diseases
Hossein Ameri, MD, PhD
9:00am – 9:30am
OCT Angiography- Innovations and Applications
Amir Kashani, MD, PhD
9:30am – 10:00am
Posterior Segment Inflammatory Disease
Narsing Rao, MD
10:00am – 10:15am
10:15am – 10:45am
Update on Innovations in AMD Treatment
Mark Barakat, MD
10:45am – 11:15am
Innovations in Vitreoretinal Surgery
Linda Lam, MD, MBA
11:15am – 11:45am
Imaging of Retinal Oxygen Delivery and Metabolism
Mahnaz Shahedi, PhD
11:45am – 12:15pm
Advances in Retinal Vascular Disease Management
Andrew Moshfeghi, MD, MBA
*Accreditation Statement: The Keck School of Medicine of the University of Southern California is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation: The Keck School of Medicine of the University of California designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Allied Health Care Professionals: Registered nurses may report up to 3.5 credit hours toward the continuing education requirement for license renewal by their state Board of Registered Nurses (BRN). CME may be noted on the license renewal application in lieu of a BRN provider number. The National Commission on Certification of Physician Assistants states that AMA accredited Category 1 courses are accepted for re certification.
Disclosure: As an organization accredited by the ACCME, The Keck School of Medicine of the University of Southern California requires everyone who is in a position to control the content of an education activity to disclose prior to the activity all relevant financial relationships with any commercial interest. All disclosed relevant financial relationships will have been resolved prior to the commencement of the activity.
Objectives: Use an interactive, case-based discussion to incorporate evidence-based data to improve diagnostic and therapeutic management of patients with these ocular disorders. Recognize and discuss the most recent techniques in the management of ocular condition. Apply current research findings to better diagnose and manage patients with ocular disease.